EDGAR Filing Documents for 0001564590-20-020178

Form 8-K - Current report:

SEC Accession No. 0001564590-20-020178

Filing Date

2020-04-30

Accepted

2020-04-30 16:10:26

Documents

Period of Report

2020-04-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	acer-8k_20200430.htm	8-K	55616
2	EX-10.1	acer-ex101_18.htm	EX-10.1	377628
3	EX-10.2	acer-ex102_19.htm	EX-10.2	188613
4	EX-99.1	acer-ex991_6.htm	EX-99.1	13875
5	GRAPHIC	go5inhc4lop4000001.jpg	GRAPHIC	2729
	Complete submission text file	0001564590-20-020178.txt		641201

Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458

Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100

Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)